首页> 外文期刊>Journal of Extracellular Vesicles >Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV‐CATCHER): A customizable purification assay designed for small‐RNA biomarker identification and evaluation of circulating small‐EVs
【24h】

Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release (EV‐CATCHER): A customizable purification assay designed for small‐RNA biomarker identification and evaluation of circulating small‐EVs

机译:通过选择的抗体和酶释放(EV捕手)捕获细胞外囊泡:设计用于小RNA生物标志物鉴定和循环小型电源的评估的可定制纯化测定

获取原文
           

摘要

Circulating nucleic acids, encapsulated within small extracellular vesicles (EVs), provide a remote cellular snapshot of biomarkers derived from diseased tissues, however selective isolation is critical. Current laboratory‐based purification techniques rely on the physical properties of small‐EVs rather than their inherited cellular fingerprints. We established a highly‐selective purification assay, termed EV‐CATCHER, initially designed for high‐throughput analysis of low‐abundance small‐RNA cargos by next‐generation sequencing. We demonstrated its selectivity by specifically isolating and sequencing small‐RNAs from mouse small‐EVs spiked into human plasma. Western blotting, nanoparticle tracking, and transmission electron microscopy were used to validate and quantify the capture and release of intact small‐EVs. As proof‐of‐principle for sensitive detection of circulating miRNAs, we compared small‐RNA sequencing data from a subset of small‐EVs serum‐purified with EV‐CATCHER to data from whole serum, using samples from a small cohort of recently hospitalized Covid‐19 patients. We identified and validated, only in small‐EVs, hsa‐miR‐146a and hsa‐miR‐126‐3p to be significantly downregulated with disease severity. Separately, using convalescent sera from recovered Covid‐19 patients with high anti‐spike IgG titers, we confirmed the neutralizing properties, against SARS‐CoV‐2 in vitro, of a subset of small‐EVs serum‐purified by EV‐CATCHER, as initially observed with ultracentrifuged small‐EVs. Altogether our data highlight the sensitivity and versatility of EV‐CATCHER. ‘A customizable, low background, high‐affinity assay for specific immuno‐capture and release of circulating small extracellular vesicles prior to small‐RNA sequencing for identification of miRNA biomarkers or in‐vitro evaluation:?The EV‐CATCHER assay (Extracellular Vesicle Capture by AnTibody of CHoice and Enzymatic Release)’.
机译:包封在小细胞外囊泡(EVS)内包封的循环核酸提供衍生自病毒组织的偏远细胞快照,但是选择性隔离是至关重要的。目前基于实验室的纯化技术依赖于小型EV的物理性质而不是其遗传的细胞指纹。我们建立了一种高度选择性纯化测定,称为EV捕手,最初是通过下一代测序设计用于低丰度小RNA尸体的高通量分析。我们通过特异性地分离和测序从尖刺到人血浆中的小鼠小rnas来证明其选择性。蛋白质印迹,纳米粒子跟踪和透射电子显微镜用于验证并量化完整的小型电源的捕获和释放。作为循环miRNA的敏感检测的原理证据,我们将小RNA测序数据与来自全血清的EV捕获器的小型血清纯化的小RNA测序数据与来自全血清的数据进行了比较,使用来自最近住院的Covid的小群组的样品-19患者。我们识别和验证,仅在小型电梯内,HSA-miR-146a和hsa-mir-126-3p,以疾病严重程度显着下降。单独使用来自Recovered Covid-19患者的康复血清高抗刺激IgG滴度,我们确认了通过EV捕手的小型EVS血清纯化的SARS-COV-2对抗SARS-COV-2的中和性质。最初用超速离心的小EVS观察。完全我们的数据突出了EV捕手的灵敏度和多功能性。 “可定制,低背景,高亲和力测定,用于特定免疫捕获和释放在小RNA测序之前的循环小细胞外囊泡,以鉴定miRNA生物标志物或体外评估:α捕获器测定(细胞外囊泡捕获通过选择和酶释放的抗体)'。

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号